Tag: Biomedical Award

Áron Mészáros | Health Professions | Research Excellence Award

Published on by WSA Awards

Mr. Áron Mészáros | Health Professions | Research Excellence Award

Hungarian University of Sport Science | Hungary

Mr. Áron Gergely Mészáros is a Hungarian strength and conditioning specialist and researcher with extensive experience in elite basketball performance and sports science. With a professional background as a former first-division basketball player, he has transitioned into high-level coaching and diagnostics, contributing to national teams and leading academies, including the Hungarian Basketball Federation and Vasas Basketball Academy. His expertise spans movement quality assessment, sport-specific performance testing, injury prevention, and load monitoring using advanced technologies such as VO₂ max analysis, lactate testing, and LPS systems. Mészáros has authored multiple peer-reviewed publications in international journals, focusing on youth athlete development and performance analytics. His work supports evidence-based training practices and contributes significantly to athlete health, performance optimization, and the advancement of sports science methodologies globally.

Citation Metrics (Scopus)

3
2
1
0

Citations
1

h-index
1

Documents
2

Citations

h-index

Documents

Featured Publications

Muhammad Ali Ibrahim Kazi | Medicine and Dentistry | Research Excellence Award

Published on by WSA Awards

Dr. Muhammad Ali Ibrahim Kazi | Medicine and Dentistry | Research Excellence Award

Anne Arundel Medical Center | United States

Dr. Muhammad Ali Ibrahim Kazi, MD, MBBS is a PGY-2 Internal Medicine resident at Anne Arundel Medical Center, Maryland, with strong academic training from Aga Khan University and international clinical experience. He has successfully completed all USMLE steps and is actively engaged in outcomes-based and real-world evidence research, particularly in gastroenterology, hepatology, inflammatory bowel disease, metabolic disorders, and GLP-1–based therapies. Dr. Kazi has multiple peer-reviewed publications, including PubMed-indexed articles and book chapters, and an extensive portfolio of ongoing multicenter cohort studies using large databases such as TriNetX. His work has been presented at major global forums including DDW, ACG, and AASLD. Beyond academia, he demonstrates strong societal impact through leadership in health education, cancer awareness, homelessness outreach, and global community service initiatives.

ORCID Profile

Featured Publications

Turkan Mutlu Yar | Medicine and Dentistry | Research Excellence Award

Published on by WSA Awards

Assist. Prof. Dr. Turkan Mutlu Yar | Medicine and Dentistry | Research Excellence Award

Ordu University Faculty of Medicine | Turkey

Dr. Turkan Mutlu Yar is a dedicated Doctor Ogretim Uyesi in the Department of Medical Parasitology at Ordu University, Faculty of Medicine, where she has been contributing to academic research, teaching, and diagnostics since 2023. She completed her PhD in Parasitology at İnönü University in 2015, with a thesis focused on the effectiveness of PCR in diagnosing Trichomonas infections in male patients. Her academic background also includes a thesis-based Master’s degree in Parasitology, a non-thesis Master’s degree in Biology Teaching, and a Bachelor’s degree in Biology from Fırat University. Dr. Yar’s research expertise spans intestinal parasites, cystic echinococcosis, trichomoniasis, zoonotic parasitic diseases, diagnostic molecular methods, and machine learning applications in parasitology. She has authored numerous peer-reviewed articles in international journals, including studies on Helicobacter pylori, Toxoplasma gondii, Toxocara species, and intestinal parasite prevalence in clinical and community settings. Her collaborative work also explores the antiparasitic effects of plant extracts, decision tree algorithms for disease severity, and risk factor modeling for parasitic infections. In addition, she has contributed multiple book chapters on parasitic diseases, zoonotic infections, liver trematodes, free-living amoebae, and hospital-acquired parasitic pathogens.

Citation Metrics (Scopus)

4
3
2
1
0

Citations
3

Documents
3

h-index
1

Citations

Documents

h-index

Featured Publications

 

Dujiang Yang | Health Professions | Best Researcher Award

Published on by WSA Awards

Dr. Dujiang Yang | Health Professions | Best Researcher Award

The Affiliated Hospital of Traditional Chinese Medicine of Southwest Medical University Spinal Surgery Group | China

Dr. Dujiang Yang is currently pursuing his graduate studies in Traditional Chinese Medicine (Orthopedics and Traumatology) at Southwest Medical University (September 2023–June 2026). Despite being in training, he has already established an exceptionally prolific academic record, demonstrating strong research capability and outstanding scientific productivity. As the first author, he has published 43 English SCI-indexed papers, one Chinese Peking University Core article, several regular English journal papers, and additional Chinese publications. His cumulative SCI impact factor as first author has reached 264.5, reflecting both depth and influence in interdisciplinary biomedical research. His publications span top-tier journals including Annals of the Rheumatic Diseases (IF=20.6), Journal of Extracellular Vesicles (IF=14.5), Advanced Science (IF=14.3), Leukemia (IF=13.4), Cardiovascular Research (IF=13.2), Angiogenesis (IF=9.2), British Journal of Pharmacology (IF=7.7), and many others across fields such as immunology, degenerative diseases, oncology, tissue engineering, and stem cell therapies. His research interests are broad yet cohesive, focusing on molecular mechanisms of disease, regenerative medicine, biomaterials, single-cell analysis, and translational therapeutic strategies. In addition to research articles, he has also contributed multiple commentary papers in SCI journals, including a notable commentary in JAMA Network Open (IF=9.7). Beyond published work, Yang also has several manuscripts under review or accepted, including research utilizing multi-omics approaches, machine learning, network pharmacology, UHPLC-Q-Orbitrap-ESI-MS, and spatial transcriptomics, further demonstrating advanced methodological skills and translational vision. His work—ranging from tendon repair, osteoarthritis treatment, muscle regeneration, virology, to stem cell-based therapy—reflects a rare integration of modern biomedical science with traditional Chinese medicine perspectives. Yang has actively contributed to multiple funded scientific research projects under the supervision of Professor Guoyou Wang. His roles include project design, experimental execution, and manuscript preparation. Key projects include: a National Natural Science Foundation project exploring mechanisms of Shaoyang Shenggu prescription in regulating IL-17/NF-κB pathways to inhibit chondrocyte senescence; and several Sichuan Provincial research grants focused on network pharmacology, TGF-β/GPX4 signaling, iron-death mechanisms, and therapeutic evaluation of traditional herbal approaches in knee osteoarthritis.

Profile: ORCID

Featured Publications

  1. (2025). Navigating the complex landscape of DPP4 inhibition in inflammation: From novel mechanisms to unresolved translational challenges. Inflammation Research.

  2. (2025). USP5-laden ApoEVs and E2F1 stabilization in disc repair: Unresolved questions on senescence, specificity and endosomal escape. Journal of Extracellular Vesicles.

  3. (2025). Advancing the tendinopathy triad: Comment on “Tendinopathy: The interplay between mechanical stress, inflammation, and vascularity”. Advanced Science.

  4. (2025). Time to move beyond treatment initiation: Implementing risk-stratified therapy in fracture liaison services. Osteoporosis International.

 

Willi Tarver | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Dr. Willi Tarver | Medicine and Dentistry | Best Researcher Award

Assistant Professor from The Ohio State University, United States

Dr. Willi L. Tarver is a distinguished Assistant Professor in the Division of Cancer Prevention and Control at The Ohio State University, where he leverages his interdisciplinary expertise to address disparities in healthcare delivery and cancer outcomes. With a strong foundation in public health informatics, behavioral oncology, and medical library sciences, Dr. Tarver’s research focuses on integrating patient-reported outcomes (PROs), electronic tools, and equity-focused interventions to better engage underserved populations in the cancer care continuum. His professional trajectory includes advanced fellowships in behavioral oncology and medical informatics, and he is actively involved in federally funded research projects. Dr. Tarver is also deeply committed to mentoring students and early-career professionals, especially from underrepresented backgrounds. His scholarly work addresses systemic issues in healthcare access and aims to develop scalable, tech-based strategies to reduce disparities. In addition to research and teaching, he plays key roles in administrative and clinical improvement initiatives within OSU’s Quality Improvement Hub. Dr. Tarver’s growing leadership within national organizations, innovative approach to equitable cancer prevention, and consistent focus on translating research into real-world applications position him as a leader in academic medicine and public health. He is a compelling nominee for the Best Researcher Award.

Professional Profile

Education

Dr. Tarver’s educational background reflects a unique and valuable combination of public health, information science, and communication, which together form the backbone of his interdisciplinary research. He earned his Doctor of Public Health (Dr.P.H.) from the University of Alabama at Birmingham, where he was also a recipient of the prestigious NCI Diversity Supplement under the Cancer Prevention and Control Training Program. Prior to this, he completed dual Master’s degrees in Public Health (MPH) and Library and Information Science (MLIS) at the University of South Florida. His foundational undergraduate training includes a B.A. in Communication from Columbus State University and an A.S. in Pre-Pharmacy from Gordon College. Dr. Tarver further sharpened his expertise through two postdoctoral fellowships: one in Behavioral Oncology at Indiana University and another in Medical Informatics at the VA Medical Center in Indianapolis. These fellowships provided him with advanced training in clinical research, data analytics, and healthcare system improvement. His broad and deep academic background allows him to bridge clinical research, informatics, and patient-centered interventions—a combination that has enabled his innovative work in cancer disparities and technology-enhanced health solutions.

Professional Experience

Dr. Tarver’s professional journey is defined by a blend of academic, clinical, and administrative roles that support his contributions to cancer prevention, health equity, and public health informatics. Currently serving as an Assistant Professor in the Division of Cancer Prevention and Control within the Department of Internal Medicine at The Ohio State University, he has held this role since 2019. Prior to this appointment, he was a postdoctoral and informatics fellow at the Roudebush VA Medical Center and Indiana University–Purdue University Indianapolis. During his time at the VA, Dr. Tarver contributed to the Center for Health Information and Communication, refining his expertise in applying informatics to support equitable healthcare delivery. His professional roles also extend into quality improvement, where he co-led the Health Equity Core at OSU’s Quality Improvement Hub from 2022 to 2024. Dr. Tarver is an active mentor in OSU’s Center for Cancer Health Equity Summer Research Program, guiding underrepresented students in impactful, community-focused projects. In addition, he participates in institutional governance as a member of OSU’s Innovation Council. Across his roles, he has demonstrated consistent leadership, interdisciplinary collaboration, and a deep commitment to improving health outcomes through equitable and data-driven approaches.

Research Interests

Dr. Tarver’s research is driven by a deep commitment to eliminating disparities in cancer prevention and control through the integration of technology, public health, and clinical practice. His primary interest lies in the development and evaluation of patient-centered technologies—particularly electronic patient-reported outcomes (ePRO) tools—to better engage underserved populations and inform health system decision-making. His projects explore how these tools can be tailored to the unique needs of minority communities, improve cancer survivorship planning, and enhance real-time communication between patients and providers. Another major area of interest is health equity, where Dr. Tarver investigates the impact of perceived discrimination, systemic biases, and cultural barriers on cancer care utilization and outcomes. Additionally, he is involved in research that evaluates educational interventions designed to reduce STEM-related biases in high school learning environments. Through his interdisciplinary work, Dr. Tarver aims to generate actionable insights that not only contribute to academic knowledge but also guide policy reforms and clinical practices. His interests span behavioral oncology, implementation science, and medical informatics, positioning him at the forefront of translational research that impacts patient lives while advancing health equity on a systemic scale.

Research Skills

Dr. Tarver possesses a robust skill set in both qualitative and quantitative research methodologies, which he applies to projects at the intersection of health equity, informatics, and cancer prevention. He is highly experienced in designing and analyzing patient-reported outcomes (PROs), particularly within underserved and minority populations. His expertise includes conducting structured interviews, participant observation, and systematic reviews—skills he actively shares as a guest lecturer in OSU’s Public Health Informatics course. Dr. Tarver is also proficient in research related to intervention development and evaluation, including randomized trials and implementation science frameworks. His grant-writing capabilities are demonstrated by his role as Principal Investigator (PI) and Co-Investigator (Co-I) on several federal and institutional research awards. He collaborates across disciplines, including clinical medicine, education, behavioral science, and information systems, to build comprehensive research designs. Additionally, he has applied informatics tools for data visualization, regulatory decision-making, and game-based learning assessments. These skills empower him to execute complex, multilevel projects with real-world applicability and high translational value. His research toolkit is complemented by strong mentorship abilities, fostering new talent and promoting equity-focused research within academic and clinical settings.

Awards and Honors

Dr. Tarver has received multiple prestigious honors that reflect his academic excellence, research promise, and commitment to advancing health equity. He was honored with the Young Investigator Award at the VA Medical Center in Indianapolis, recognizing his early-career contributions to cancer prevention research. His selection for the VA Advanced Fellowship in Medical Informatics further highlights his potential as a leader in data-driven health solutions. As a fellow in Behavioral Oncology at Indiana University, he gained national recognition for his work integrating psychological, behavioral, and technological approaches to patient-centered care. Notably, he was a recipient of the Diversity Supplement from the National Cancer Institute (NCI) through the University of Alabama at Birmingham, affirming his focus on minority health and health disparities. Earlier in his academic journey, he was awarded the ALSTARS Scholarship at the University of South Florida for academic merit and leadership. These accolades not only reflect his dedication to research excellence but also underscore the national recognition he has received for addressing some of the most pressing challenges in health equity, cancer care, and public health education.

Conclusion

In conclusion, Dr. Willi L. Tarver stands out as an exceptionally well-rounded and impactful academic professional whose contributions significantly advance the fields of cancer prevention, public health informatics, and health equity. His ability to bridge research, mentorship, education, and clinical innovation uniquely qualifies him for the Best Researcher Award. Through interdisciplinary training, funded research projects, and active mentorship, Dr. Tarver continues to address real-world health disparities and improve patient outcomes, particularly in underserved communities. His track record as a Principal Investigator and collaborator on diverse research grants highlights his leadership and collaborative capabilities. Moreover, his mentorship of minority students and involvement in institutional quality improvement initiatives reflect a long-term investment in both people and systems. With a growing portfolio of honors, active society memberships, and educational contributions, Dr. Tarver is positioned for continued excellence and recognition in the academic and public health communities. His work exemplifies the values of translational research, social impact, and scientific integrity, making him a deserving and distinguished candidate for the Best Researcher Award.

Publications Top Notes

1. Family structure and risk behaviors: the role of the family meal in assessing likelihood of adolescent risk behaviors
📅 Year: 2014
✍️ Authors: S. Goldfarb, W.L. Tarver, B. Sen
📰 Psychology Research and Behavior Management, pp. 53–66
📈 Citations: 83

2. The use of cancer-specific patient-centered technologies among underserved populations in the United States: systematic review
📅 Year: 2019
✍️ Authors: W.L. Tarver, D.A. Haggstrom
📰 Journal of Medical Internet Research, 21(4), e10256
📈 Citations: 68

3. Growth dynamics of patient-provider internet communication: trend analysis using the Health Information National Trends Survey (2003 to 2013)
📅 Year: 2018
✍️ Authors: W.L. Tarver, T. Menser, B.W. Hesse, T.J. Johnson, E. Beckjord, E.W. Ford, et al.
📰 Journal of Medical Internet Research, 20(3), e109
📈 Citations: 56

4. A systematic review of the association between family meals and adolescent risk outcomes
📅 Year: 2015
✍️ Authors: S.S. Goldfarb, W.L. Tarver, J.L. Locher, J. Preskitt, B. Sen
📰 Journal of Adolescence, 44, pp. 134–149
📈 Citations: 56

5. Exploring disparities and variability in perceptions and self-reported colorectal cancer screening among three ethnic subgroups of US Blacks
📅 Year: 2010
✍️ Authors: C.K. Gwede, C.M. William, K.B. Thomas, W.L. Tarver, G.P. Quinn, et al.
📰 Oncology Nursing Forum, 37(5), 581
📈 Citations: 51

6. A randomized trial to compare a tailored web-based intervention and tailored phone counseling to usual care for increasing colorectal cancer screening
📅 Year: 2018
✍️ Authors: V.L. Champion, S.M. Christy, W. Rakowski, W.G. Gathirua-Mwangi, W.L. Tarver, et al.
📰 Cancer Epidemiology, Biomarkers & Prevention, 27(12), 1433–1441
📈 Citations: 35

7. The impact of health information technology on cancer care across the continuum: a systematic review and meta-analysis
📅 Year: 2016
✍️ Authors: W.L. Tarver, N. Menachemi
📰 Journal of the American Medical Informatics Association, 23(2), 420–427
📈 Citations: 35

8. Perceptions of colorectal cancer among three ethnic subgroups of US blacks: a qualitative study
📅 Year: 2011
✍️ Authors: C.K. Gwede, E. Jean-Francois, G.P. Quinn, S. Wilson, W.L. Tarver, K.B. Thomas, et al.
📰 Journal of the National Medical Association, 103(8), 669–680
📈 Citations: 35

9. Allostatic load: a framework to understand breast cancer outcomes in Black women
📅 Year: 2021
✍️ Authors: S. Obeng-Gyasi, W. Tarver, R.C. Carlos, B.L. Andersen
📰 NPJ Breast Cancer, 7(1), 100
📈 Citations: 34

10. Factors associated with adherence to mammography screening among insured women differ by income levels
📅 Year: 2018
✍️ Authors: W. Gathirua-Mwangi, A. Cohee, W.L. Tarver, A. Marley, E. Biederman, et al.
📰 Women’s Health Issues, 28(5), 462–469
📈 Citations: 34

Yana Zhang | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Assoc. Prof. Dr. Yana Zhang | Medicine and Dentistry | Best Researcher Award

Associate Professor from Department of Otolaryngology-Head and Neck Surgery, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China

Dr. Yana Zhang is an accomplished academic and researcher in the field of Otorhinolaryngology–Head and Neck Surgery, currently serving as an Associate Professor at the Third Affiliated Hospital of Sun Yat-sen University. She holds a Ph.D. from Tongji Medical College, Huazhong University of Science and Technology, China, and has completed a postdoctoral fellowship at Northwestern University, USA. With over a decade of research and clinical experience, Dr. Zhang has established herself as a leading figure in allergy and airway inflammation research. Since joining Sun Yat-sen University through the prestigious “Hundred Talents Program” in 2020, she has been spearheading multiple high-impact research projects. She has published more than 40 peer-reviewed articles in journals such as Nature Immunology, J Allergy Clin Immunol, J Exp Med, and Am J Respir Crit Care Med, many as first or corresponding author. Her research focuses on the molecular mechanisms underlying allergic inflammation and chronic rhinosinusitis. Dr. Zhang plays influential roles in several national academic and medical committees and is a regular reviewer for high-impact journals and research foundations. Her work is recognized for its translational value, aiming to improve treatment outcomes for patients with allergic diseases and ENT disorders.

Professional Profile

Education

Dr. Yana Zhang pursued her higher education in medicine and specialized in Otorhinolaryngology–Head and Neck Surgery. She earned her Ph.D. from Tongji Medical College at Huazhong University of Science and Technology in 2014, one of China’s most respected institutions in medical research. Her doctoral work focused on immunological mechanisms and inflammatory processes in chronic rhinosinusitis and other airway-related disorders, laying the groundwork for her later research. She subsequently enhanced her academic portfolio by undertaking postdoctoral training at Northwestern University in the United States from 2016 to 2020. This international experience enabled her to refine her research methods and establish collaborations with world-renowned immunologists and clinical scientists. Her training at Northwestern offered her exposure to advanced biomedical research techniques and allowed her to integrate global best practices into her work. This comprehensive academic background has provided her with a solid foundation to pursue advanced research in translational medicine, particularly in immune-mediated diseases of the upper respiratory tract. Her education reflects a blend of rigorous Chinese medical training and cutting-edge international research exposure, positioning her as a global scholar with a deep understanding of both clinical and experimental approaches.

Professional Experience

Dr. Zhang began her professional academic career after completing her Ph.D. in 2014. Following this, she undertook a postdoctoral fellowship at Northwestern University in the United States from 2016 to 2020, where she worked on translational research projects focused on immunoregulation and inflammatory diseases. This experience significantly expanded her research expertise and network. In 2020, she returned to China to join the Third Affiliated Hospital of Sun Yat-sen University as an Associate Professor through the university’s highly competitive “Hundred Talents Program.” In this role, she leads a dynamic research team working on inflammatory mechanisms in chronic rhinosinusitis and allergy-related comorbidities. Dr. Zhang also holds several influential academic appointments, including expert reviewer roles for the Ministry of Education and the National Natural Science Foundation of China. She serves on various national committees under the Chinese Medical Association and other professional bodies, contributing to policy, research direction, and academic evaluations. She also plays a key role in mentoring graduate students and guiding young researchers. Her multidisciplinary experience bridges clinical practice and molecular science, allowing her to translate laboratory findings into potential therapies for ENT and allergic conditions.

Research Interests

Dr. Yana Zhang’s research centers on immunological mechanisms and therapeutic strategies targeting eosinophilic inflammation and allergic airway diseases. Her work addresses chronic rhinosinusitis with nasal polyps (CRSwNP), a debilitating and recurring inflammatory disorder, and aims to unravel the molecular underpinnings of steroid resistance and epithelial barrier dysfunction. She has explored novel pathways involving fatty acids, IL-17A, vitamin D, and extracellular vesicles in allergic disease models. Her recent studies investigate the roles of epithelium-derived chemokines, Charcot-Leyden crystals, and immune checkpoints in modulating inflammation and tissue remodeling. Another central focus of her research is the interaction between environmental factors, such as air pollution, and the immunopathology of rhinitis and asthma. Dr. Zhang’s goal is to translate her laboratory findings into effective therapeutic strategies that can be applied in clinical settings. Her research also spans the field of immune metabolism, including succinate signaling and its effect on regulatory T cells, with implications for systemic autoimmune and allergic diseases. Her interdisciplinary work combines molecular biology, clinical otorhinolaryngology, and immunotherapy to address urgent healthcare challenges in allergy and airway inflammation.

Research Skills

Dr. Zhang is equipped with a comprehensive skill set in both clinical and molecular research. Her expertise includes cellular immunology, molecular biology, transcriptomics, histopathology, and translational medicine. She is proficient in designing and conducting in vivo and in vitro models of airway inflammation, including murine models of eosinophilic rhinosinusitis. She has extensive experience in flow cytometry, ELISA, immunohistochemistry, RNA sequencing, confocal microscopy, and CRISPR-Cas9 gene editing technologies. Her postdoctoral training at Northwestern University further enhanced her proficiency in advanced immunological assays, including Treg stability assays, metabolite analysis, and cell differentiation studies. Dr. Zhang is skilled in developing predictive models and statistical algorithms to interpret clinical outcomes and endotypes in allergic patients. Additionally, she collaborates with bioinformatics experts to analyze large datasets, facilitating biomarker discovery and patient stratification. Her capacity to bridge bench-side experimentation with clinical relevance makes her a leader in translational allergy research. Dr. Zhang’s multidisciplinary research environment allows her to apply both clinical acumen and lab-based expertise to uncover new therapeutic avenues in chronic inflammatory diseases.

Awards and Honors

Dr. Yana Zhang has received multiple accolades that reflect her scholarly excellence and leadership in biomedical research. Most notably, she was selected as a Young Top Talent under the Guangdong “Pearl River Talent Program” in 2022, a prestigious recognition for emerging scientific leaders in China. In 2020, she was recruited through the “Hundred Talents Program” at Sun Yat-sen University, a national initiative to attract top researchers to Chinese academic institutions. These honors underscore her scientific impact and potential to contribute to national innovation goals. In addition to these major recognitions, Dr. Zhang has been invited to serve as a grant reviewer for the National Natural Science Foundation of China, a testament to her credibility and leadership in the scientific community. She is also an expert evaluator for doctoral dissertations under the Ministry of Education. Her editorial and peer-review responsibilities for internationally reputed journals further reflect her standing in the academic field. Collectively, these awards and responsibilities highlight her commitment to advancing research, mentoring junior scientists, and shaping the future of otorhinolaryngology and immunology in China and beyond.

Conclusion

Dr. Yana Zhang stands out as an exceptional researcher and academic whose work has had a profound impact on the field of immunology and otorhinolaryngology. Her career reflects a harmonious blend of rigorous academic training, international experience, and a deep commitment to translational medicine. Through cutting-edge research on eosinophilic inflammation and allergic diseases, she has significantly advanced our understanding of the pathophysiological mechanisms underlying chronic airway disorders. Her contributions are well-documented through a robust portfolio of publications in top-tier scientific journals and her leadership in multiple national research projects. Furthermore, her active involvement in academic societies and committees showcases her dedication to the scientific community. Dr. Zhang’s efforts not only enhance clinical outcomes for patients but also influence national policy and research directions. Her vision of integrating basic research with clinical application makes her a key figure in developing personalized treatments for allergy and ENT disorders. With continued support and collaboration, Dr. Zhang is poised to make even greater strides in medical science and to serve as a role model for future researchers in China and globally.

Publications Top Notes

  1. Vitamin D impedes eosinophil chemotaxis via inhibiting glycolysis‑induced CCL26 expression in eosinophilic chronic rhinosinusitis with nasal polyps

  • Year: 2025

  • Authors: Weiqiang Huang, Yana Zhang, Yue Li, Junming Ma, Xia Li, Yanjie Jiang, Jianqi Wang, Haotian Wu, Xiaohong Chen, Zizhen Huang, Xifu Wu, Xiaoping Lai, Donglin Li, Lihong Chang, Gehua Zhang

2. Succinate drives gut inflammation by promoting FOXP3 degradation through a molecular switch

  • Year: 2025

  • Authors: Hai Wang, Danqing Hu, Yang Cheng, Qiong Gao, Kun Liu, Nikita L. Mani, Amy Y. Tang, Radhika Iyer, Beixue Gao, Leyu Sun, Qi Zhou, Qin Yu, Samuel E. Weinberg, Xiaoyu Zhang, Yingzi Cong, Parambir S. Dulai, Yana Zhang, Zheng Liu, Deyu Fang

 

 

Mohamed Balata | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Assist. Prof. Dr. Mohamed Balata | Medicine and Dentistry | Best Researcher Award

Mansoura University hospital, Egypt

Dr. Mohamed Balata is a dedicated and accomplished Egyptian general and colorectal surgeon affiliated with Mansoura University Hospital, Egypt. With a robust academic background and extensive clinical training, Dr. Balata has built a reputation in both surgical practice and academic teaching. His clinical interests primarily revolve around laparoscopic and minimally invasive colorectal surgeries, as well as emerging techniques in bariatric and laser-assisted procedures. Over the past decade, he has developed advanced surgical skills and contributed to significant peer-reviewed publications, reflecting a balance between academic research and clinical excellence. Dr. Balata currently serves as a Consultant and Lecturer at the Faculty of Medicine, Mansoura University, where he is actively involved in training medical students and residents. His contributions to international scientific literature and his award-winning research on rectocele repair underscore his commitment to evidence-based surgery. Known for his expertise in managing complex surgical cases and for his continuous participation in workshops and professional development courses, Dr. Balata demonstrates strong leadership in surgical education and innovation. His collaborative spirit, excellent communication skills, and drive for clinical research position him as a distinguished professional within the field of surgery, particularly in colorectal procedures and functional outcomes.

Professional Profile

Education

Dr. Mohamed Balata possesses a well-rounded educational background in general and colorectal surgery, obtained from one of Egypt’s leading medical institutions—Mansoura University. He earned his MD in General Surgery in December 2019, following a Master’s degree in the same specialty in September 2014. His academic journey began with obtaining a medical license from the Ministry of Health and Population in March 2011, which marked the formal start of his clinical career. Notably, in November 2009, he completed an MD Degree in General and Colorectal Surgery with an Excellent with Honors grade from the Faculty of Medicine, Mansoura University. This early academic distinction laid the foundation for a career steeped in clinical rigor and academic excellence. Dr. Balata’s education has been supplemented by his participation in numerous professional development workshops and certified training programs, including international publication courses and advanced laparoscopic surgery sessions. His continuous educational efforts reflect a commitment to lifelong learning and adapting to evolving surgical technologies. This foundation has enabled him to effectively translate theoretical knowledge into practical surgical proficiency and has paved the way for his progression into roles of higher academic and clinical responsibility.

Professional Experience

Dr. Mohamed Balata has accumulated over a decade of progressive clinical and academic experience in general and colorectal surgery. He currently serves as a Consultant and Lecturer at the General Surgery Department of Mansoura University Hospital, a position he has held since January 2020. His prior roles include Assistant Lecturer (2014–2020) and Teaching Assistant (2014) at the same institution. These academic appointments are complemented by his earlier clinical work, including his tenure as a Specialist of General Surgery at the Health Affairs Directorate under Egypt’s Ministry of Health. His surgical residency from 2011 to 2014 at Mansoura University Hospitals provided foundational experience in managing a diverse range of general surgical cases. Dr. Balata’s career also includes roles as a General Practitioner and completion of an internship year at Mansoura University Hospitals. Throughout these roles, he has not only refined his surgical skills but also demonstrated dedication to medical education by actively engaging in training medical students, surgical residents, and board-certified doctors. His teaching contributions, coupled with advanced clinical practice, reflect a strong dual commitment to both patient care and academic medicine, making him a well-rounded professional in the medical and surgical community.

Research Interest

Dr. Mohamed Balata’s research interests lie primarily in general and colorectal surgery, with a focused emphasis on minimally invasive and functional outcomes of surgical interventions. His work investigates the comparative effectiveness of various surgical approaches, including laparoscopic versus open procedures, and their impact on postoperative recovery and quality of life. One of his notable research contributions explored the functional and sexual quality of life following transperineal versus transvaginal repair of anterior rectocele, which was recognized internationally. Additionally, he has shown keen interest in stem cell applications for anal sphincter repair, manometric assessments in rectocele management, and innovations in pilonidal disease treatments, including laser techniques. Dr. Balata’s scholarly output reflects a clinical-research integration, where surgical decision-making is informed by empirical findings. His multidisciplinary approach includes collaboration with gastroenterology, gynecology, and radiology departments to deliver holistic patient care. He also explores surgical education and skill development through observational studies and clinical trials. His research not only advances surgical protocols but also contributes to academic literature and evidence-based guidelines, especially within the field of functional colorectal disorders. Dr. Balata remains committed to expanding this portfolio, aiming to improve patient outcomes and enhance surgical standards regionally and globally.

Research Skills

Dr. Mohamed Balata is equipped with a comprehensive suite of research skills that align with his clinical expertise in general and colorectal surgery. He has hands-on experience in designing and executing clinical trials, as evidenced by his randomized controlled study on rectocele repair outcomes. His methodological competencies include data analysis using SPSS and Stata, literature reviews, and manuscript preparation for peer-reviewed journals. Dr. Balata is well-versed in both qualitative and quantitative research techniques and is proficient in international scientific publishing. He has collaborated with interdisciplinary teams to explore various aspects of surgical innovation and patient care. His familiarity with ethical standards and research protocols ensures compliance in human subject research. Additionally, he possesses strong presentation and communication skills, having participated in international conferences and surgical workshops. He has the capability to translate complex clinical findings into practical applications, a trait that enhances his teaching and mentorship roles. Furthermore, his work in observational studies, surgical outcome measures, and patient quality of life assessments demonstrates a strong understanding of clinical research metrics. These research skills not only support his academic publications but also enable him to contribute meaningfully to evidence-based surgical practice and policy-making.

Awards and Honors

Dr. Mohamed Balata has received notable recognition for his contributions to surgical research and clinical excellence. Most prominently, he was awarded for the Best Publication by the American Society of Colon and Rectal Surgeons (ASCRS) in 2020. This prestigious accolade was granted for his study titled “Functional outcome and Sexual-Related Quality of Life after Transperineal versus Transvaginal Repair of Anterior Rectocele,” which was published in the Diseases of the Colon & Rectum journal. The award highlights not only the academic merit of his work but also its clinical relevance in advancing surgical practice. In addition to international recognition, Dr. Balata has consistently demonstrated academic excellence from his early education, including graduating with honors. His research continues to attract attention for its innovative approaches and direct impact on improving patient outcomes. These honors underscore his dedication to blending surgical expertise with rigorous academic inquiry. Furthermore, his active membership in the Egyptian Society of Surgeons and the Egyptian Group of Colorectal Surgeons positions him within key professional networks that support ongoing learning and recognition. These achievements validate Dr. Balata’s standing as a committed and impactful researcher in the medical and surgical fields.

Conclusion

Dr. Mohamed Balata stands out as a highly competent and research-driven colorectal surgeon who has successfully integrated clinical practice with academic scholarship. His robust educational foundation, combined with his professional experience in one of Egypt’s leading medical institutions, reflects both depth and breadth of expertise. Through his internationally recognized research, he has addressed critical aspects of surgical outcomes, quality of life, and minimally invasive techniques. His ability to conduct, publish, and present high-quality research underscores his capacity for independent investigation and scientific communication. Furthermore, Dr. Balata’s contributions as a lecturer and mentor indicate a commitment to shaping the next generation of surgeons. He consistently pursues academic excellence through workshops, professional society memberships, and participation in national and international forums. While his current achievements are substantial, opportunities for further interdisciplinary collaboration and grant acquisition could expand the reach and application of his work. In summary, Dr. Balata is a well-rounded academic surgeon who meets the criteria for the Best Researcher Award through his strong publication record, commitment to clinical innovation, and active involvement in surgical education and research. His profile exemplifies excellence in translational surgical science and continuous professional development.

Publications Top Notes

  1. Title: Outcomes of Concomitant Laparoscopic Sleeve Gastrectomy and Hiatal Hernia Repair on Gastroesophageal Reflux Disease in Patients with Severe Obesity: A Propensity Score-Matched Analysis

  2. Authors: El Nakeeb, Ayman M.; Aldossary, Hassan Maged; Zaid, Ahmed; Alnakeeb, Kareem; Attia, Mohamed Sabry

  3. Journal: Obesity Surgery: Including Laparoscopy and Allied Care

  4. Year: 2025

 

Christine Shaw | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Dr. Christine Shaw| Medicine and Dentistry | Best Researcher Award

Dr. Christine Shaw University of Alabama Birmingham, United States.

Dr. Christine M. Shaw is an Instructor and GEM/SEMPH Fellow in the Department of Emergency Medicine at the University of Alabama at Birmingham. She holds an MD from the Medical University of South Carolina and advanced degrees in public health and tropical medicine. Her clinical work spans both adult and pediatric emergency medicine at UAB Hospital and Children’s of Alabama. A passionate researcher and educator, Dr. Shaw has received multiple awards for her work in emergency care, homelessness, health equity, and global medicine. She has presented at national conferences and co-founded several community and educational initiatives. Her commitment to underserved populations and academic excellence makes her a strong candidate for the Best Researcher Award.

Professional Profile

Education

Dr. Christine Shaw holds an MSPH (Master of Science in Public Health) from the UAB School of Public Health (2025 expected), a Diploma in Tropical Medicine and Hygiene from the UAB Gorgas Institute (2024), an MD from the Medical University of South Carolina (2020), and a BS from the University of South Carolina (2012). Her academic foundation bridges basic science, clinical medicine, and global public health. Through her education, she developed a strong interdisciplinary skill set, preparing her to tackle complex healthcare challenges both locally and globally. Her continuous academic advancement illustrates a deep commitment to lifelong learning and evidence-based medicine, solidifying her as a thoughtful scholar-practitioner in the field of emergency medicine.

Professional Experience

Dr. Shaw brings robust clinical and academic experience, currently serving as an Emergency Medicine physician at UAB Hospital and Children’s of Alabama. She completed her EM residency at LSU Health Shreveport (2023) and is a current GEM/SEMPH fellow at UAB. Her roles include academic instruction, research mentorship, and frontline emergency care. Beyond clinical duties, she has served as co-director and advisor for medical student organizations, led curriculum development, and collaborated on international health initiatives. Her leadership extends to free clinics, global outreach, and medical education. This diverse experience showcases her ability to integrate patient care, teaching, and research, reinforcing her qualifications for academic recognition.

Research Interests

Dr. Shaw’s research centers on health disparities, emergency care for vulnerable populations, provider education, and global health systems. Her projects include healthcare needs assessments for people experiencing homelessness, provider preferences in airway management, and the use of ultrasound in resource-limited settings. She also explores the intersection of housing insecurity and substance use in emergency settings. With training in tropical medicine and public health, she integrates clinical findings with systemic solutions to improve patient outcomes. Dr. Shaw’s commitment to applied, community-informed research reflects a broader vision to improve emergency care delivery and public health infrastructure locally and globally.

Awards and Honors

Dr. Shaw has received numerous academic and research honors, including first place at the 2022 EMerald Coast Conference for her intubation simulation study. As an undergraduate, she earned the Magellan Scholar Research Grant, Discovery Day 1st Place in Biology Research, and Who’s Who Among America’s Universities recognition. In medical school, she received the Milton Paul Kleinholz Endowed Scholarship at Meharry Medical College. These accolades reflect her long-standing commitment to academic excellence and impactful research. Her record of award-winning work across different stages of her career underscores her potential as a leader in medical research and supports her candidacy for further recognition.

Conclusion

Dr. Christine Marie Shaw is a strong candidate for the Best Researcher Award in the early-career category. Her academic rigor, service-oriented mindset, and award-winning research mark her as a future leader in emergency medicine scholarship. While still developing her research portfolio, her trajectory reflects significant promise and alignment with the award’s goals.

Publications Top Notes

Dong-bo Liu | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Dr. Dong-bo Liu | Medicine and Dentistry | Best Researcher Award

Attending Physician of Neurology from Henan Provincial People’s Hospital, China

Dr. Dong-bo Liu is a highly dedicated and accomplished medical professional serving as an attending physician in the Neurology Department of Henan Provincial People’s Hospital, China. With a Doctor of Medicine degree, Dr. Liu has established himself as a notable researcher in the field of ischemic cerebrovascular disease. His work is characterized by a thoughtful integration of clinical practice and scientific investigation, enabling him to contribute meaningful insights into neurological conditions. Dr. Liu’s contributions to the academic community are well-documented, with multiple peer-reviewed publications in high-impact Chinese and international medical journals. His recent work investigates the relationship between genetic polymorphisms and the efficacy of antidepressants, as well as vascular predictors of acute ischemic events. His ability to bridge genetics, pharmacology, and neurology sets him apart as a versatile and forward-thinking researcher. In addition to his clinical responsibilities, Dr. Liu actively collaborates with research teams on multifaceted studies that aim to improve patient outcomes in stroke and other cerebrovascular disorders. Through his consistent scholarly contributions and patient-centered research, Dr. Liu has become a respected figure in neurology. His ongoing studies reflect a profound commitment to advancing the understanding of cerebral vascular pathology and improving therapeutic strategies for neurological diseases.

Professional Profile

Education

Dr. Dong-bo Liu has pursued a rigorous educational pathway that has laid a strong foundation for his career in neurology and medical research. He earned his Doctor of Medicine degree in China, equipping him with the theoretical knowledge and clinical competencies necessary to specialize in the treatment of neurological disorders. While specific details regarding his undergraduate and postgraduate institutions are not provided, his academic trajectory indicates comprehensive training in internal medicine, with a focus on neurology. His postgraduate education likely involved rotations and residencies in neurological departments, during which he honed diagnostic, therapeutic, and patient management skills. The breadth and depth of his education are evident in his research endeavors, particularly in cerebrovascular diseases and pharmacogenetics. Furthermore, Dr. Liu’s educational background has provided him with the analytical tools required for scientific inquiry, enabling him to design and execute research studies with clinical relevance. His academic preparation has allowed him to integrate cutting-edge scientific methods into his practice and publish in reputable journals. As a result, Dr. Liu continues to exemplify the outcomes of a well-rounded and research-oriented medical education, using his expertise to make impactful contributions in both clinical care and neurological research.

Professional Experience

Dr. Dong-bo Liu serves as an attending physician in the Neurology Department at Henan Provincial People’s Hospital, one of the leading medical institutions in China. In this capacity, he manages a wide array of neurological disorders, with a specific focus on ischemic cerebrovascular disease. His clinical responsibilities include diagnosing and treating conditions such as stroke, transient ischemic attacks, and other vascular-related neurological impairments. Dr. Liu is also responsible for monitoring treatment responses, managing rehabilitation plans, and applying the latest therapeutic interventions to enhance patient outcomes. In addition to his hands-on clinical role, Dr. Liu is deeply involved in research and academic activities. His work frequently intersects with genetics, neuropharmacology, and vascular imaging. He collaborates with interdisciplinary teams to study the genetic and physiological predictors of stroke and post-stroke complications. Dr. Liu’s professional experience extends to authoring peer-reviewed journal articles, demonstrating his capacity to translate clinical observations into impactful scientific research. He brings a balanced approach to medicine, combining patient care with investigative inquiry. Through his role at Henan Provincial People’s Hospital, Dr. Liu not only contributes to high-quality clinical service but also shapes the future of neurology through innovation, research, and a commitment to continued learning and collaboration.

Research Interests

Dr. Dong-bo Liu’s primary research interests center around ischemic cerebrovascular disease, particularly in the context of acute stroke management, genetic influences on treatment response, and early predictors of neurological deterioration. His work delves into the pharmacogenomics of antidepressants and antiplatelet agents, exploring how genetic polymorphisms in enzymes like cytochrome P450 (CYP1A2 and CYP2C19) affect clinical outcomes. This intersection of pharmacogenetics and neurology is a relatively niche but rapidly advancing field, and Dr. Liu’s studies offer valuable insights into personalized medicine. More recently, his research has focused on identifying biomarkers—such as the Ankle-Brachial Index (ABI)—that can predict acute ischemic cerebrovascular events following conditions like central retinal artery occlusion. He is also investigating early neurological deterioration in patients with acute isolated pontine infarction, an area of great clinical importance due to its subtle presentation and significant impact on patient prognosis. By identifying risk factors and potential early indicators, Dr. Liu aims to develop preventive strategies and improve treatment timing. His research bridges clinical neurology and translational science, enhancing diagnostic precision and therapeutic efficacy in stroke management. Ultimately, Dr. Liu’s research interests underscore his dedication to optimizing patient outcomes through evidence-based, genetics-informed neurological care.

Research Skills

Dr. Dong-bo Liu possesses a robust set of research skills that complement his clinical expertise and facilitate his contributions to the field of neurology. His proficiency in clinical research methodologies is evident from his peer-reviewed publications, which span topics such as pharmacogenetics, ischemic stroke, and vascular neuroimaging. Dr. Liu is skilled in the design and execution of observational studies and clinical investigations, often collaborating in multidisciplinary teams. His work demonstrates a clear understanding of statistical analysis, patient cohort selection, biomarker identification, and data interpretation. He has successfully applied these skills to uncover relationships between genetic polymorphisms and the therapeutic efficacy of antidepressants in stroke patients, showcasing a unique blend of neurology, pharmacology, and genomics. Dr. Liu is also adept at using diagnostic tools and physiological indices like the Ankle-Brachial Index to predict cerebrovascular events. Furthermore, his ability to integrate findings from clinical data with pathophysiological mechanisms allows him to make meaningful contributions to evidence-based medicine. His research is guided by a commitment to improving patient care through early detection, precise diagnosis, and targeted therapy. Overall, Dr. Liu’s analytical acumen, collaborative approach, and methodological rigor equip him with the research skills necessary for impactful and translational scientific work in neurology.

Awards and Honors

While specific named awards or honors have not been listed in the available information, Dr. Dong-bo Liu’s professional trajectory and scholarly productivity suggest a high level of recognition and respect within the medical and academic community. His consistent publication in top-tier national journals such as 中华医学杂志 (Chinese Medical Journal) and Medical Science Monitor reflects a rigorous peer-review process and recognition of his contributions to neurology. Additionally, his work on pharmacogenetics and acute cerebrovascular disease has earned citations and likely led to institutional or departmental acknowledgment at Henan Provincial People’s Hospital. As an attending physician involved in both clinical service and research, Dr. Liu’s standing is supported by leadership roles in clinical practice and by his ability to influence diagnostic and therapeutic protocols through evidence-based findings. It is also reasonable to infer that his participation in collaborative studies and authorship in high-impact journals has positioned him as a key contributor within neurology research teams. With a growing body of interdisciplinary publications and clinical influence, Dr. Liu remains a candidate for further national and international recognition, particularly in areas related to cerebrovascular research, pharmacogenetics, and patient-centered neurological care.

Conclusion

Dr. Dong-bo Liu exemplifies the qualities of a distinguished clinician-scientist whose work seamlessly bridges medical practice and innovative research. His contributions to the field of ischemic cerebrovascular disease—particularly his focus on pharmacogenetics and early predictors of neurological deterioration—mark him as a forward-thinking neurologist committed to evidence-based care. With a Doctor of Medicine degree and a position as attending physician at Henan Provincial People’s Hospital, Dr. Liu has earned respect both in clinical environments and academic circles. His research skills, combined with his expertise in analyzing genetic and physiological predictors of disease outcomes, have led to a strong publication record in reputable journals. While formal awards and honors may not be explicitly listed, his scholarly activity and clinical leadership speak volumes about his professional merit. Dr. Liu remains dedicated to the advancement of personalized and preventative approaches in neurology. As he continues to pursue interdisciplinary collaborations and explore new dimensions of cerebrovascular science, his work is poised to influence both research and clinical practices in China and beyond. Given his accomplishments and ongoing contributions, Dr. Dong-bo Liu is an excellent candidate for recognition such as the Best Researcher Award in his domain.

Publications Top Notes

  1. Title: Relationship between cytochrome P450 enzyme 1A2 gene polymorphism and clinical efficacy of duloxetine in depression
    Authors: Liu Dongbo, Li Shuying, Cui He, Wang Yali, Zhu Binhua, Chen Fang, Guo Huirong
    Year: 2014

  2. Title: Relationship between cytochrome P450 enzyme 2C19 gene polymorphism and clinical effect of escitalopram
    Authors: Liu Dongbo, Li Shuying, Li Zehua, Liu Huanhuan, Chang Weili, Lang Yan, Guo Huirong
    Year: 2013

  3. Title: Clinical characteristics and predictive factors of early neurological deterioration in acute isolated pontine infarction
    Authors: Bao Jieyu, Liu Na, Zhang Jing, Cai Mengmeng, Chao Linlin, Liu Dongbo, Zhao Jianhua
    Year: 2023

  4. Title: Relationship between central visual acuity and transient retinal ischemic attack in eyes with non-arteritic central retinal artery occlusion
    Authors: Liu Dongbo, Zhang Bingxian, Zhao Qiongrui, Zhang Jiewen, Zhao Jianhua, Li Fugui
    Year: 2024

  5. Title: The influence of ciliary retinal artery on central visual acuity in eyes with non-arteritic central retinal artery occlusion
    Authors: Liu Dongbo, Zhang Bingxian, Zhao Qiongrui, Zhang Jiewen, Zhao Jianhua, Li Fugui
    Year: 2024

  6. Title: Ankle-Brachial Index as a Predictor of Acute Ischemic Cerebrovascular Event After Central Retinal Artery Occlusion
    Authors: Liu, D. B., Zhang, B. X., Zhou, Y., et al.
    Year: 2025

  7. Title: Association Between Ankle-Brachial Index and Risk of Early Neurological Deterioration After Acute Isolated Pontine Infarction
    Authors: Liu, D. B., Zhang, B. X., Zhou, Y., et al.
    Year: 2025